[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ellis et al., 1983 - Google Patents

Control of pulsatile LH release in male rats

Ellis et al., 1983

Document ID
1409121146014834734
Author
Ellis G
Desjardins C
Fraser H
Publication year
Publication venue
Neuroendocrinology

External Links

Snippet

Distinct, short-term pulses of pituitary luteinizing hormone (LH) release are a characteristic feature of tonic LH secretion in normal rats. LH pulses are more pronounced, more frequent, and more regular in castrated rats. Using castrated rats, we sought to identify the basis of the …
Continue reading at karger.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00—Drug, bio-affecting and body treating compositions
    • Y10S514/866—Diabetes

Similar Documents

Publication Publication Date Title
Ellis et al. Control of pulsatile LH release in male rats
RIVIER et al. Effect of neurotensin, substance P and morphine sulfate on the secretion of prolactin and growth hormone in the rat
Schürmeyer et al. Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion
Ching Correlative surges of LHRH, LH and FSH in pituitary stalk plasma and systemic plasma of rat during proestrus: effect of anesthetics
FUCHS et al. Release of oxytocin and prolactin by suckling in rabbits throughout lactation
Rivier et al. Mediation by Corticotropin Releasing Factor(CRF) of Adenohypophysial Hormone Secretion
JUDD et al. Inhibition of gonadotropin and prolactin release by dopamine: effect of endogenous estradiol levels
Legros et al. Dose-response relationship between plasma oxytocin and cortisol and adrenocorticotropin concentrations during oxytocin infusion in normal men
Imakawa et al. Endocrine changes during restoration of estrous cycles following induction of anestrus by restricted nutrient intake in beef heifers
Samson et al. In vitro stimulation of prolactin release by vasoactive intestinal peptide
Fraser et al. Decreased pituitary responsiveness and inhibition of the luteinizing hormone surge and ovulation in the stumptailed monkey (Macaca arctoides) by chronic treatment with an agonist of luteinizing hormone-releasing hormone
Guillemin et al. Growth hormone-releasing factor: chemistry and physiology
Neidhart et al. Hyperprolactinaemia in hypophysectomized or intact male rats and the development of adjuvant arthritis.
Fraser et al. Effects of an LH-releasing hormone antagonist on the secretion of LH, FSH, prolactin and ovarian steroids at different stages of the luteal phase in the stumptailed macaque (Macaca arctoides)
Arnold et al. Caffeine stimulates β-endorphin release in blood but not in cerebrospinal fluid
Wehrenberg et al. A noninvasive functional lesion of the hypothalamo-pituitary axis for the study of growth hormone-releasing factor
WARDLAW et al. Failure of β-endorphin to stimulate prolactin release in the pituitary stalk-sectioned monkey
Muralidhar et al. Inhibition of in vivo pituitary release of luteinizing hormone in lactating rats by exogenous prolactin
YU et al. Gonadotropin-releasing hormone-associated peptide exerts a prolactin-inhibiting and weak gonadotropin-releasing activity in vivo
Milenkovic et al. Effects of thymosin alpha-1 on pituitary hormone release
Tannenbaum et al. Failure of β-endorphin antiserum, naloxone, and naltrexone to alter physiologic growth hormone and insulin secretion
Veldhuis et al. Divergent influences of calcium ions on releasing factor-stimulated anterior pituitary hormone secretion in normal man
Li et al. Stimulation of prolactin secretion in the pig: central effects of relaxin and the antiprogesterone RU 486
Veldhuis et al. Divergent influences of the structurally dissimilar calcium entry blockers, diltiazem and verapamil, on thyrotropin-and gonadotropin-releasing hormone-stimulated anterior pituitary hormone secretion in man
Gaynor et al. 5-Hydroxytryptaminergic receptor-stimulated growth hormone secretion occurs independently of changes in peripheral somatostatin concentration